- Home
- NVCR vs ARR Comparison
NVCR vs ARR Comparison
Compare NVCR & ARR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | NVCR | ARR |
|---|---|---|
| Founded | 2000 | 2008 |
| Country | Switzerland | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.0B | 2.0B |
| IPO Year | 2015 | N/A |
Fundamental Metrics
Financial Performance| Metric | NVCR | ARR |
|---|---|---|
| Price | $17.55 | $16.42 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 6 | 3 |
| Target Price | ★ $28.08 | $18.50 |
| AVG Volume (30 Days) | 1.7M | ★ 4.0M |
| Earning Date | 04-30-2026 | 04-22-2026 |
| Dividend Yield | N/A | ★ 16.69% |
| EPS Growth | ★ 21.79 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $655,353,000.00 | N/A |
| Revenue This Year | $7.72 | N/A |
| Revenue Next Year | $6.74 | N/A |
| P/E Ratio | ★ N/A | $27.18 |
| Revenue Growth | ★ 8.28 | N/A |
| 52 Week Low | $9.82 | $13.98 |
| 52 Week High | $21.45 | $19.31 |
Technical Indicators
Market Signals| Indicator | NVCR | ARR |
|---|---|---|
| Relative Strength Index (RSI) | 56.67 | 44.75 |
| Support Level | $12.85 | $16.10 |
| Resistance Level | $18.48 | $17.72 |
| Average True Range (ATR) | 1.21 | 0.30 |
| MACD | 0.08 | 0.04 |
| Stochastic Oscillator | 39.72 | 53.54 |
Price Performance
Historical ComparisonAbout NVCR NovoCure Limited
NovoCure Ltd is an oncology company with a proprietary platform technology in the United States. Its business involves the development, manufacture, and commercialization of Tumor Treating Fields (TTFields) devices, including Optune Gio and Optune Lua, for the treatment of solid tumor cancers. Its pipeline consists of Trident, Lunar-2, Panova-3, Metis, and other products and technologies for the treatment of Glioblastoma, Non-small cell lung cancer, and Pancreatic cancer. Geographically, the company derives the majority of its revenue from the United States and the rest from Germany, Japan, and other markets.
About ARR ARMOUR Residential REIT Inc.
ARMOUR Residential REIT Inc operate in the U.S. and invest in fixed rate residential, adjustable rate and hybrid adjustable rate residential MBS issued or guaranteed by U.S. GSEs or guaranteed by Ginnie Mae. It also invest in U.S. Treasury Securities and money market instruments.